Crescent Biopharma, Inc. (CBIO)
Crescent Biopharma, Inc. (CBIO) Insider Trading
Directors, officers and holders of more than 10% of CBIO report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 63 transactions on file: 3 with code P, 16 with code S and 31 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Brumm Joshua T | Chief Executive Officer | S Sale | 7,837 | $16.71 | $130,956 |
| Sep 18, 2026 | McNeill Jonathan | President and COO | S Sale | 3,839 | $16.71 | $64,150 |
| Sep 16, 2026 | Brumm Joshua T | Chief Executive Officer | S Sale | 1,610 | $17.90 | $28,819 |
| Sep 16, 2026 | McNeill Jonathan | President and COO | S Sale | 731 | $17.90 | $13,085 |
| Sep 16, 2026 | Lynch Ryan | See Remarks | S Sale | 240 | $17.90 | $4,296 |
| Sep 16, 2026 | Pinkas Jan | Chief Scientific Officer | S Sale | 658 | $17.90 | $11,778 |
| Sep 16, 2026 | Im Ellie Eunkyung | Chief Medical Officer | S Sale | 623 | $17.90 | $11,152 |
| Sep 16, 2026 | Scalzo Richard William | Chief Financial Officer | S Sale | 568 | $17.90 | $10,167 |
| Sep 16, 2026 | Bispham Barbara Harlin | See Remarks | S Sale | 620 | $17.90 | $11,098 |
| Jul 16, 2026 | Fairmount Funds Management LLC | Director | P Purchase | 853,450 | $14.50 | $12,375,025 |
| Jul 16, 2026 | Fairmount Funds Management LLC | Director | P Purchase | 525,897 | $14.50 | $7,624,981 |
| Jun 22, 2026 | McNeill Jonathan | President and COO | S Sale | 20,549 | $17.99 | $369,677 |
| Jun 22, 2026 | Lynch Ryan | See Remarks | S Sale | 465 | $17.99 | $8,365 |
| Jun 22, 2026 | Pinkas Jan | Chief Scientific Officer | S Sale | 1,288 | $17.99 | $23,171 |
| Jun 22, 2026 | Scalzo Richard William | Chief Financial Officer | S Sale | 1,112 | $17.99 | $20,005 |
| Jun 22, 2026 | Bispham Barbara Harlin | See Remarks | S Sale | 1,218 | $17.99 | $21,912 |
| Jun 22, 2026 | Im Ellie Eunkyung | Chief Medical Officer | S Sale | 1,219 | $17.99 | $21,930 |
| Jun 22, 2026 | Brumm Joshua T | Chief Executive Officer | S Sale | 42,305 | $17.99 | $761,067 |
| Jun 2, 2026 | Moran Susan | Director | A Award | 11,050 | Not measured | Not measured |
| Jun 2, 2026 | Balcom Alexandra | Director | A Award | 11,050 | Not measured | Not measured |
| Jun 2, 2026 | Lubner David Charles | Director | A Award | 11,050 | Not measured | Not measured |
| Jun 2, 2026 | Fairmount Funds Management LLC | Director | A Award | 11,050 | Not measured | Not measured |
| Jun 2, 2026 | Violin Jonathan | Director | A Award | 11,050 | Not measured | Not measured |
| Dec 15, 2025 | Im Ellie Eunkyung | Chief Medical Officer | A Award | 65,190 | Not measured | Not measured |
| Dec 15, 2025 | Pinkas Jan | Chief Scientific Officer | A Award | 5,000 | Not measured | Not measured |
| Dec 15, 2025 | Scalzo Richard William | Chief Financial Officer | A Award | 14,422 | Not measured | Not measured |
| Dec 15, 2025 | Scalzo Richard William | Chief Financial Officer | A Award | 5,000 | Not measured | Not measured |
| Dec 15, 2025 | McNeill Jonathan | President and COO | A Award | 19,507 | Not measured | Not measured |
| Dec 15, 2025 | McNeill Jonathan | President and COO | A Award | 6,000 | Not measured | Not measured |
| Dec 15, 2025 | Lynch Ryan | See Remarks | A Award | 8,378 | Not measured | Not measured |
| Dec 15, 2025 | Lynch Ryan | See Remarks | A Award | 4,000 | Not measured | Not measured |
| Dec 15, 2025 | Bispham Barbara Harlin | See Remarks | A Award | 12,422 | Not measured | Not measured |
| Dec 15, 2025 | Bispham Barbara Harlin | See Remarks | A Award | 6,000 | Not measured | Not measured |
| Dec 15, 2025 | Doughty Christopher Grant | Chief Business Officer | A Award | 14,714 | Not measured | Not measured |
| Dec 15, 2025 | Doughty Christopher Grant | Chief Business Officer | A Award | 8,000 | Not measured | Not measured |
| Dec 15, 2025 | Brumm Joshua T | Chief Executive Officer | A Award | 45,117 | Not measured | Not measured |
| Dec 15, 2025 | Brumm Joshua T | Chief Executive Officer | A Award | 10,000 | Not measured | Not measured |
| Dec 15, 2025 | Im Ellie Eunkyung | Chief Medical Officer | A Award | 16,298 | Not measured | Not measured |
| Dec 15, 2025 | Im Ellie Eunkyung | Chief Medical Officer | A Award | 5,000 | Not measured | Not measured |
| Dec 15, 2025 | Pinkas Jan | Chief Scientific Officer | A Award | 70,025 | Not measured | Not measured |
| Dec 15, 2025 | Scalzo Richard William | Chief Financial Officer | A Award | 57,688 | Not measured | Not measured |
| Dec 15, 2025 | McNeill Jonathan | President and COO | A Award | 78,029 | Not measured | Not measured |
| Dec 15, 2025 | Lynch Ryan | See Remarks | A Award | 33,512 | Not measured | Not measured |
| Dec 15, 2025 | Bispham Barbara Harlin | See Remarks | A Award | 72,185 | Not measured | Not measured |
| Dec 15, 2025 | Doughty Christopher Grant | Chief Business Officer | A Award | 58,855 | Not measured | Not measured |
| Dec 15, 2025 | Brumm Joshua T | Chief Executive Officer | A Award | 180,467 | Not measured | Not measured |
| Dec 15, 2025 | Pinkas Jan | Chief Scientific Officer | A Award | 17,507 | Not measured | Not measured |
| Dec 8, 2025 | McNeill Jonathan | President and COO | A Award | 172,836 | Not measured | Not measured |
| Dec 8, 2025 | Brumm Joshua T | Chief Executive Officer | A Award | 345,672 | Not measured | Not measured |
| Dec 4, 2025 | Fairmount Funds Management LLC | Director | P Purchase | 1,360,000 | $13.41 | $18,237,600 |
The full Form 4 history is on the CBIO company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.